Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.fairchem.in | |
Market Cap | 1,453.52 Cr. | |
Enterprise Value(EV) | 1,485.82 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 42.80 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 26.08 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 26.08 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 189.12 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 5.90 | Calculated using Price: 1,116.30 |
Dividend Yield | 1.16 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.30 Cr. | 13,020,902 Shares |
FaceValue | 10 | |
Company Profile | ||
Fairchem is India's largest manufacturer of Dimer acid used in many consumer products including paints. Fairchem also processes Tocopherol which is used in formulating Natural Vitamin-E. |
1 Day |
|
-2.02% |
1 Week |
|
-0.86% |
1 Month |
|
-13.54% |
3 Month |
|
-39.33% |
6 Month |
|
-27.48% |
1 Year |
|
-44.94% |
2 Year |
|
+85.60% |
5 Year |
|
|
10 Year |
|
3 years | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 30.52 | 30.08 | 33.88 | |
Return on Capital Employed (%) | 25.34 | 29.86 | 37.75 | |
Return on Assets (%) | 15.86 | 17.80 | 23.31 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 127 | 169 | 232 | 246 | |
Non Curr. Liab. | 29 | 39 | 25 | 16 | |
Curr. Liab. | 63 | 51 | 67 | 38 | |
Minority Int. | |||||
Equity & Liab. | 219 | 259 | 324 | 300 | |
Non Curr. Assets | 144 | 161 | 187 | 194 | |
Curr. Assets | 75 | 98 | 137 | 106 | |
Misc. Exp. not W/O | |||||
Total Assets | 219 | 259 | 324 | 300 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 306 | 397 | 643 | 730 | |
Other Income | 7 | 0 | 0 | 0 | |
Total Income | 313 | 397 | 644 | 730 | |
Total Expenditure | -258 | -328 | -538 | -640 | |
PBIDT | 55 | 69 | 105 | 90 | |
Interest | -7 | -7 | -7 | -7 | |
Depreciation | -6 | -7 | -7 | -8 | |
Taxation | -8 | -13 | -23 | -19 | |
Exceptional Items | |||||
PAT | 35 | 42 | 68 | 56 | |
Adjusted EPS | 33 | 52 | 43 |
Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 31 | 40 | 40 | |
Cash Fr. Inv. | -24 | -23 | -34 | |
Cash Fr. Finan. | -7 | -17 | -6 | |
Net Change | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 |
Tue, 31 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30(6) read with Schedule III-Part A - Para A - Clause 15(a) of SEBI (LODR) Regulations 2015 kindly note that on Wednesday 8th February 2023 at 3.30 p.m. the Company has scheduled an Earnings Con-call to discuss earnings of the Company for the quarter / nine months ended December 31 2022.The con-call will be coordinated by our external investor relations advisor - M/s. Valorem Advisors Mumbai. Other relevant details for participating in the con-call are attached herewith. |
Fri, 20 Jan 2023
Board Meeting Intimation for Notice Of Board Meeting Fairchem Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 inter alia to consider and approve Notice is hereby given pursuant to regulation 29(1)(a) of SEBI (LODR) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 6th February 2023 through Audio Visual means to inter alia consider and adopt the un-audited Financial Results (under Ind-AS) for the quarter ended 31st December 2022 along with Limited Review Report thereon (b) any other business with the permission of the Chair. |
Thu, 29 Dec 2022
Closure of Trading Window Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform that the Trading Window for dealing in the Equity Shares of the Company will remain closed with effect from January 01 2023 till 48 hours after the declaration of unaudited financial results duly subjected to Limited Review by Statutory Auditors for the quarter ending December 31 2022. |
Fri, 03 Feb 2023 |
|
|
|
|
|